Skip to the page

Data / Drug companies / Trospium chloride

Trospium chloride: 22 companies and 29 products in the FDA NDC directory

Trospium chloride is listed in the FDA National Drug Code Directory by 22 companies, with 29 products in commercial distribution. 29 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; capsule, extended release; tablet, and the newest product started marketing on November 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
22
Products
29
Generic (ANDA) products
29 (100.0%)
Application numbers
10
Routes
Oral
openFDA record search
api.fda.gov

Companies that list trospium chloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Bryant Ranch Prepack3tablet, film coated; capsule, extended releaseGeneric drugs (ANDA)June 7, 2013
Bryant Ranch Prepack2capsule, extended release; tablet, film coatedGeneric drugs (ANDA)June 7, 2013
Bryant Ranch Prepack2capsule, extended release; tablet, film coatedGeneric drugs (ANDA)June 7, 2013
Major Pharmaceuticals2tablet, film coatedGeneric drugs (ANDA)August 27, 2026
Padagis US LLC2capsule, extended release; tablet, film coatedGeneric drugs (ANDA)June 7, 2013
Remedyrepack Inc.2tablet, film coatedGeneric drugs (ANDA)October 8, 2026
Actavis Pharma, Inc.1capsule, extended releaseGeneric drugs (ANDA)October 12, 2012
American Health Packaging1tablet, film coatedGeneric drugs (ANDA)November 1, 2026
Aphena Pharma Solutions - Tennessee, LLC1tablet, film coatedGeneric drugs (ANDA)November 16, 2015
BluePoint Laboratories1capsule, extended releaseGeneric drugs (ANDA)July 10, 2020
Chartwell RX, LLC1tablet, film coatedGeneric drugs (ANDA)August 30, 2016
Cipla USA Inc.1tablet, film coatedGeneric drugs (ANDA)September 23, 2016
Exelan Pharmaceuticals Inc.1tablet, film coatedGeneric drugs (ANDA)July 11, 2017
Glenmark Pharmaceuticals Inc., USA1tablet, film coatedGeneric drugs (ANDA)August 13, 2010
Golden State Medical Supply, Inc.1capsule, extended releaseGeneric drugs (ANDA)October 12, 2012
Granules Pharmaceuticals Inc.1capsule, extended releaseGeneric drugs (ANDA)August 19, 2020
Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.1tablet, film coatedGeneric drugs (ANDA)August 30, 2016
Macleods Pharmaceuticals Limited1tabletGeneric drugs (ANDA)June 18, 2024
PD-Rx Pharmaceuticals, Inc.1tablet, film coatedGeneric drugs (ANDA)November 17, 2010
Proficient Rx LP1capsule, extended releaseGeneric drugs (ANDA)August 19, 2020
Slate Run Pharmaceuticals, LLC1capsule, extended releaseGeneric drugs (ANDA)June 21, 2021
Zameer Pharmaceuticals LLC1tablet, film coatedGeneric drugs (ANDA)December 3, 2022

Dosage forms

Dosage formProductsShare
Tablet, film coated1862.1%
Capsule, extended release1034.5%
Tablet13.4%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)29100%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.